Clinical Trial Update: Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the effects of carvedilol on anthracycline-induced cardiotoxicity in cancer patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Hospital Sirio-Libanes | Conditions: Cancer | Phase 4 | Status: UNKNOWN